title: [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). III. Secular changes in susceptibility].
abstract: Susceptibilities of Enterococcus faecalis, Staphylococcus aureus, Citrobacter spp., Enterobacter spp., Escherichia coli, Klebsiella spp., Proteus mirabilis, Pseudomonas aeruginosa and Serratia spp. isolated from patients with urinary tract infections (UTIs) in 10 hospitals during June 1994 to May 1995 to various antimicrobial agents were compared with those in the same period of previous years according to a classification, uncomplicated UTIs, complicated UTIs without indwelling catheter, and complicated UTIs with indwelling catheter. No remarkable changes were found in susceptibilities of Citrobacter spp., Enterobacter spp. and Serratia spp. The susceptibilities of E. faecalis to amikacin and quinolones were better than those in 1993. As for S. aureus, susceptible strains to all drugs increased in uncomplicated UTIs. Against E. coli in 1993, the antimicrobial activities of piperacillin, cefotiam and aminoglycosides have decreased, however, in 1994, these activities have turned to the better state. As for Klebsiella spp. susceptible strains to ABPC decreased. The susceptibilities of P. mirabilis to all drugs except minocycline were good. Against P. aeruginosa in 1993, the activities of aminoglycosides have decreased, but, in 1994, these activities have turned to the better state. These data should be considered in clinical treatment of various urinary tract infections.
authors.affiliation: Department of Urology, Sapporo Medical University, School of Medicine.
authors.forename: Y
authors.initials: Y
authors.lastname: Kumamoto
authors.forename: T
authors.initials: T
authors.lastname: Hirose
authors.forename: A
authors.initials: A
authors.lastname: Yokoo
authors.forename: Y
authors.initials: Y
authors.lastname: Hikichi
authors.forename: S
authors.initials: S
authors.lastname: Shigeta
authors.forename: Y
authors.initials: Y
authors.lastname: Shiraiwa
authors.forename: H
authors.initials: H
authors.lastname: Kameoka
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Tazaki
authors.forename: H
authors.initials: H
authors.lastname: Iri
authors.forename: H
authors.initials: H
authors.lastname: Uchida
authors.forename: Y
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: S
authors.initials: S
authors.lastname: Matsuda
authors.forename: M
authors.initials: M
authors.lastname: Fujime
authors.forename: K
authors.initials: K
authors.lastname: Fujita
authors.forename: R
authors.initials: R
authors.lastname: Kitagawa
authors.forename: J
authors.initials: J
authors.lastname: Igari
authors.forename: T
authors.initials: T
authors.lastname: Oguri
authors.forename: N
authors.initials: N
authors.lastname: Kosakai
authors.forename: K
authors.initials: K
authors.lastname: Yamaguchi
authors.forename: F
authors.initials: F
authors.lastname: Kashitani
authors.forename: S
authors.initials: S
authors.lastname: Yonezu
authors.forename: Y
authors.initials: Y
authors.lastname: Yamanaka
authors.forename: M
authors.initials: M
authors.lastname: Takaha
authors.forename: F
authors.initials: F
authors.lastname: Iori
mesh_terms: D042462:4-Quinolones; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D002511:Cephalosporins / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology*; D014552:Urinary Tract Infections / Q000382:microbiology*
chemical_list: D042462:4-Quinolones; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D010406:Penicillins